{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:40:09Z","timestamp":1790127609830,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13570-3","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:59:16Z","timestamp":1760950756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical pharmacist-led medication review in patients with sepsis and septic shock in the intensive care unit: a non-randomized controlled study"],"prefix":"10.1186","volume":"25","author":[{"given":"M\u00fczeyyen","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes Emir","family":"\u0130lerler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"2","key":"13570_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/SUR.2017.278","volume":"19","author":"LM Napolitano","year":"2018","unstructured":"Napolitano LM. Sepsis 2018: definitions and guideline changes. Surg Infect (Larchmt). 2018;19(2):117\u201325. https:\/\/doi.org\/10.1089\/SUR.2017.278.","journal-title":"Surg Infect (Larchmt)"},{"issue":"8","key":"13570_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/JAMA.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/JAMA.2016.0287.","journal-title":"JAMA"},{"issue":"10219","key":"13570_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"issue":"3","key":"13570_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/EPIDEMIOLOGIA5030032","volume":"5","author":"L La Via","year":"2024","unstructured":"La Via L, Cammarota G, Gibiino G, Pantanetti S, Bellan M, Pirozzi C, et al. The global burden of sepsis and septic shock. Epidemiologia. 2024;5(3):456. https:\/\/doi.org\/10.3390\/EPIDEMIOLOGIA5030032.","journal-title":"Epidemiologia"},{"issue":"4","key":"13570_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0972-5229.180042","volume":"20","author":"JV Divatia","year":"2016","unstructured":"Divatia JV, Amin PR, Ramakrishnan N, Kapadia FN, Todi S, Sahu S, et al. Intensive care in india: the Indian intensive care case mix and practice patterns study. Indian J Crit Care Med. 2016;20(4):216\u201325. https:\/\/doi.org\/10.4103\/0972-5229.180042.","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"13570_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/JAMA.2014.5804","volume":"312","author":"V Liu","year":"2014","unstructured":"Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90\u20132. https:\/\/doi.org\/10.1001\/JAMA.2014.5804.","journal-title":"JAMA"},{"issue":"11","key":"13570_CR7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","volume":"17","author":"FR Machado","year":"2017","unstructured":"Machado FR, Cavalcanti AB, Bozza FA, Ferreira EM, Carrara FSA, Angeles VD, et al. The epidemiology of sepsis in Brazilian intensive care units (SPREAD): an observational study. Lancet Infect Dis. 2017;17(11):1180\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(17)30322-5.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"13570_CR8","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/CCM.0000000000001876","volume":"44","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Harrison DA, Rowan KM. Differences in impact of definitional elements on mortality precludes international comparisons of sepsis Epidemiology\u2014A cohort study. Crit Care Med. 2016;44(12):2223\u201330. https:\/\/doi.org\/10.1097\/CCM.0000000000001876.","journal-title":"Crit Care Med"},{"key":"13570_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2013-1","volume":"22","author":"N Baykara","year":"2018","unstructured":"Baykara N, Akal\u0131n H, Arslanta\u015f MK, Hanc\u0131 V, \u00c7a\u011flayan \u00c7, Kahveci F, et al. Epidemiology of sepsis in intensive care units in turkey: a multicenter, point-prevalence study. Crit Care. 2018;22:1\u201314.","journal-title":"Crit Care"},{"issue":"11","key":"13570_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/S00134-021-06506-Y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/S00134-021-06506-Y.","journal-title":"Intensive Care Med"},{"key":"13570_CR11","unstructured":"PCNE. Classification for drug related problems. Version V8. 2003."},{"key":"13570_CR12","unstructured":"Pharmaceutical Care Network Europe. The PCNE Classification V 9.1 [Internet]. 2020 [cited 2025 Jul 16]. Available from: https:\/\/www.pcne.org\/upload\/files\/417_PCNE_classification_V9-1_final.pdf"},{"key":"13570_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1345\/aph.1D182","volume":"38","author":"JWF Van Mil","year":"2004","unstructured":"Van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859\u201367.","journal-title":"Ann Pharmacother"},{"key":"13570_CR14","doi-asserted-by":"publisher","first-page":"100302","DOI":"10.1016\/j.rcsop.2023.100302","volume":"11","author":"N Jimmy","year":"2023","unstructured":"Jimmy N, Upadhya M, Jaison JM, Sidheque S, Sundaramurthy H, Nemichandra SC, et al. A clinical Pharmacist-led approach on reducing drug related problems among patients with neurological disorders: an interventional study. Explor Res Clin Soc Pharm. 2023;11:100302. https:\/\/doi.org\/10.1016\/j.rcsop.2023.100302.","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"13570_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, et al. International consensus guidelines for the optimal use of the polymyxins. Pharmacotherapy. 2019;39(1):10\u201339. https:\/\/doi.org\/10.1002\/phar.2209.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"13570_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/cid\/ciw815","volume":"64","author":"NS Britt","year":"2017","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparative effectiveness and safety of Standard-, Medium-, and High-Dose daptomycin strategies for the treatment of Vancomycin-Resistant enterococcal bacteremia. Clin Infect Dis. 2017;64(5):605\u201313. https:\/\/doi.org\/10.1093\/cid\/ciw815.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"13570_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"PD Tamma","year":"2012","unstructured":"Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012;25(3):450\u201370. https:\/\/doi.org\/10.1128\/CMR.05041-11.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"13570_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1592\/phco.26.6.735","volume":"26","author":"CA Bond","year":"2006","unstructured":"Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in united States hospitals. Pharmacotherapy. 2006;26(6):735\u201347. https:\/\/doi.org\/10.1592\/phco.26.6.735.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"13570_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.sapharm.2024.02.006","volume":"20","author":"AM Fentie","year":"2024","unstructured":"Fentie AM, Huluka SA, Gebremariam GT, Gebretekle GB, Abebe E, Fenta TG. Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: a systematic review and meta-analysis. Res Soc Adm Pharm. 2024;20(5):487\u201397. https:\/\/doi.org\/10.1016\/j.sapharm.2024.02.006.","journal-title":"Res Soc Adm Pharm"},{"issue":"11","key":"13570_CR20","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/JCPT.13784","volume":"47","author":"YE Ayhan","year":"2022","unstructured":"Ayhan YE, Karakurt S, Sancar M. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in turkey: A non-randomized controlled study. J Clin Pharm Ther. 2022;47(11):1867\u201374. https:\/\/doi.org\/10.1111\/JCPT.13784.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"13570_CR21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/S11096-019-00909-0","volume":"41","author":"C Chapuis","year":"2019","unstructured":"Chapuis C, Roustit M, Bal G, Schwebel C, Pansu P, David-Tchouda S, et al. Integrating a pharmacist into an anaesthesiology and critical care department: is this worthwhile? Int J Clin Pharm. 2019;41(6):1491\u20138. https:\/\/doi.org\/10.1007\/S11096-019-00909-0.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"13570_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/S11096-018-0763-0","volume":"41","author":"RR Martins","year":"2019","unstructured":"Martins RR, Silva LT, Lopes FM. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit. Int J Clin Pharm. 2019;41(1):179\u201388. https:\/\/doi.org\/10.1007\/S11096-018-0763-0.","journal-title":"Int J Clin Pharm"},{"key":"13570_CR23","doi-asserted-by":"publisher","first-page":"1473719","DOI":"10.3389\/FMED.2024.1473719","volume":"11","author":"B \u00d6zgan","year":"2024","unstructured":"\u00d6zgan B, Ayhan YE, Apikoglu S, Karakurt S, Li H, Zhan Z. Clinical pharmacist interventions in nutrition- and drug-related problems in critically ill patients with renal dysfunction: a non-randomized controlled study. Front Med (Lausanne). 2024;11:1473719. https:\/\/doi.org\/10.3389\/FMED.2024.1473719.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"13570_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4274\/TJPS.GALENOS.2022.08455","volume":"20","author":"C Enver","year":"2023","unstructured":"Enver C, Ert\u00fcrk \u015eengel B, Sancar M, Korten V, Okuyan B. Medication reconciliation service in hospitalized patients with infectious diseases during COVID-19 pandemic: an observational study. Turk J Pharm Sci. 2023;20(4):210\u20137. https:\/\/doi.org\/10.4274\/TJPS.GALENOS.2022.08455.","journal-title":"Turk J Pharm Sci"},{"key":"13570_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2147\/TCRM.S61821","volume":"10","author":"CG Molino","year":"2014","unstructured":"Molino CG, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG. Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with HIV. Ther Clin Risk Manag. 2014;10:631\u20139. https:\/\/doi.org\/10.2147\/TCRM.S61821.","journal-title":"Ther Clin Risk Manag"},{"key":"13570_CR26","unstructured":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf. G*Power Software (Version 3.1.9.7) [Computer software]. Available from: http:\/\/www.gpower.hhu.de\/"},{"key":"13570_CR27","unstructured":"Shareef J, Sandeep B, Shastry CS. Assessment of drug related problems in patients with cardiovascular diseases in a tertiary care teaching hospital. J Pharm Care. [Internet]. Available from: https:\/\/jpc.tums.ac.ir\/index.php\/jpc\/article\/view\/49"},{"key":"13570_CR28","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification [Internet]. [cited 2025 Feb 24]. Available from: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification"},{"key":"13570_CR29","unstructured":"UpToDate\u00ae. Wolters Kluwer Health Inc. [Internet]. Available from: https:\/\/www.uptodate.com [Accessed 2025 Jul 21]."},{"key":"13570_CR30","unstructured":"IBM Micromedex\u00ae Drug Information [Internet]. IBM Corporation. Available from: https:\/\/www.micromedexsolutions.com [Accessed 2025 Jul 21]."},{"key":"13570_CR31","unstructured":"Lexicomp\u00ae Drug Interactions [Internet]. Hudson (OH): Wolters Kluwer Health, Inc. Available from: https:\/\/www.uptodate.com\/drug-interactions [Accessed 21 Jul 2025]."},{"key":"13570_CR32","unstructured":"Antimicrobial Therapy, Inc. Sanford guide to antimicrobial therapy online [Internet]. Sperryville (VA): Antimicrobial Therapy, Inc.; [cited 2025 Jul 21]. Available from: https:\/\/www.sanfordguide.com"},{"key":"13570_CR33","unstructured":"Turkish Medicines and Medical Devices Agency (TMMDA). Drug information system [Internet]. Ankara: TMMDA; [cited 2025 Jul 21]. Available from: https:\/\/www.titck.gov.tr"},{"key":"13570_CR34","volume-title":"IBM SPSS statistics for Windows, version 25.0","author":"IBM Corp","year":"2017","unstructured":"IBM Corp. IBM SPSS statistics for Windows, version 25.0. Armonk, NY: IBM Corp; 2017."},{"issue":"1","key":"13570_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-022-07494-5","volume":"22","author":"A Albayrak","year":"2022","unstructured":"Albayrak A, Ba\u015fgut B, B\u0131kmaz GA, Karahalil B. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. BMC Health Serv Res. 2022;22(1):1\u20137. https:\/\/doi.org\/10.1186\/S12913-022-07494-5.","journal-title":"BMC Health Serv Res"},{"key":"13570_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/TCRM.S59187","volume":"10","author":"SP Jiang","year":"2014","unstructured":"Jiang SP, Zhu ZY, Wu XL, Lu XY, Zhang XG, Wu BH. Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study. Ther Clin Risk Manag. 2014;10:405\u201312. https:\/\/doi.org\/10.2147\/TCRM.S59187.","journal-title":"Ther Clin Risk Manag"},{"key":"13570_CR37","doi-asserted-by":"publisher","DOI":"10.21203\/RS.3.RS-3247955\/V1","author":"N S\u00fcrmelio\u011flu","year":"2023","unstructured":"S\u00fcrmelio\u011flu N, Demirkan K, Karako\u00e7 E, G\u00fcnd\u00fcz M, \u00d6zcengiz D. The impact of the clinical pharmacist\u2019s intervention on the appropriate antibiotic therapy of septic patients: a non-randomized controlled study. Res Square. 2023. https:\/\/doi.org\/10.21203\/RS.3.RS-3247955\/V1.","journal-title":"Res Square"},{"key":"13570_CR38","doi-asserted-by":"publisher","first-page":"571906","DOI":"10.3389\/FPHAR.2020.571906","volume":"11","author":"XX Li","year":"2020","unstructured":"Li XX, Zhou Y, Chen Y, Gong Y, Xie J, Zhao H, et al. Drug-Related problems identified during pharmacy intervention and consultation: implementation of an intensive care unit pharmaceutical care model. Front Pharmacol. 2020;11:571906. https:\/\/doi.org\/10.3389\/FPHAR.2020.571906.","journal-title":"Front Pharmacol"},{"issue":"1","key":"13570_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/JCPT.13265","volume":"46","author":"LH Chiang","year":"2021","unstructured":"Chiang LH, Huang YL, Tsai TC. Clinical pharmacy interventions in intensive care unit patients. J Clin Pharm Ther. 2021;46(1):128\u201333. https:\/\/doi.org\/10.1111\/JCPT.13265.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"13570_CR40","doi-asserted-by":"publisher","first-page":"e0253588","DOI":"10.1371\/JOURNAL.PONE.0253588","volume":"16","author":"M Jaam","year":"2021","unstructured":"Jaam M, Naseralallah LM, Hussain TA, Pawluk SA. Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis. PLoS ONE. 2021;16(6):e0253588. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0253588.","journal-title":"PLoS ONE"},{"issue":"1","key":"13570_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/PUBMED\/FDY216","volume":"42","author":"LS Mostafa","year":"2020","unstructured":"Mostafa LS, Sabri NA, El-Anwar AM, Shaheen SM. Evaluation of pharmacist-led educational interventions to reduce medication errors in emergency hospitals: a new insight into patient care. J Public Health (Oxf). 2020;42(1):169\u201374. https:\/\/doi.org\/10.1093\/PUBMED\/FDY216.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"13570_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/ejhpharm-2015-000751","volume":"23","author":"ET Johansen","year":"2016","unstructured":"Johansen ET, Haustreis SM, Mowinckel AS, Ytreb\u00f8 LM. Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU. Eur J Hosp Pharm. 2016;23(3):158\u201362. https:\/\/doi.org\/10.1136\/ejhpharm-2015-000751.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"13570_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","volume":"25","author":"MH Kollef","year":"2021","unstructured":"Kollef MH, Shorr AF, Bassetti M, Timsit JF, Micek ST, Michelson AP, et al. Timing of antibiotic therapy in the ICU. Crit Care. 2021;25(1):360. https:\/\/doi.org\/10.1186\/s13054-021-03787-z.","journal-title":"Crit Care"},{"issue":"4","key":"13570_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/CCM.0000000000004212","volume":"48","author":"KA Corl","year":"2020","unstructured":"Corl KA, Zeba F, Caffrey AR, Hermenau M, Lopes V, Phillips G, et al. Delay in antibiotic administration is associated with mortality among septic shock patients with Staphylococcus aureus bacteremia. Crit Care Med. 2020;48(4):525\u201332. https:\/\/doi.org\/10.1097\/CCM.0000000000004212.","journal-title":"Crit Care Med"},{"key":"13570_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2193-1801-3-34","volume":"3","author":"JM Kim","year":"2014","unstructured":"Kim JM, Lee Y, Lee SH, Jang EJ, Oh YH, Lee SJ, et al. Development of clinical pharmacy services for intensive care units in Korea. Springerplus. 2014;3:34. https:\/\/doi.org\/10.1186\/2193-1801-3-34.","journal-title":"Springerplus"},{"issue":"5","key":"13570_CR46","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/CC9278","volume":"14","author":"JE Klopotowska","year":"2010","unstructured":"Klopotowska JE, Kuiper R, Van Kan HJ, De Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174. https:\/\/doi.org\/10.1186\/CC9278.","journal-title":"Crit Care"},{"issue":"9","key":"13570_CR47","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1503\/cmaj.080869","volume":"180","author":"E Camir\u00e9","year":"2009","unstructured":"Camir\u00e9 E, Moyen E, Stelfox HT. Medication errors in critical care: risk factors, prevention and disclosure. CMAJ. 2009;180(9):936\u201343. https:\/\/doi.org\/10.1503\/cmaj.080869.","journal-title":"CMAJ"},{"issue":"7","key":"13570_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/pds.1761","volume":"18","author":"L Joshua","year":"2009","unstructured":"Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18(7):639\u201345.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"18","key":"13570_CR49","first-page":"5801","volume":"25","author":"MS Da\u011fdelen","year":"2021","unstructured":"Da\u011fdelen MS, Ayhan YE, Y\u0131lmaz E, Er\u00e7in E, Akbulut G, Sancar M. Evaluation of potential drug\u2013drug interactions in intensive care unit. Eur Rev Med Pharmacol Sci. 2021;25(18):5801\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"13570_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.farma.2024.06.003","volume":"49","author":"FM Carizio","year":"2025","unstructured":"Carizio FM, Rizzato L, Rodrigues RM, et al. Pharmacotherapy assessment and adverse drug reactions in older patients admitted to intensive care. Farm Hosp. 2025;49(3):148\u201353.","journal-title":"Farm Hosp"},{"issue":"4","key":"13570_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","volume":"277","author":"DC Classen","year":"1997","unstructured":"Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301\u20136.","journal-title":"JAMA"},{"issue":"4","key":"13570_CR52","first-page":"274","volume":"21","author":"A \u00c7ak\u0131r","year":"2024","unstructured":"\u00c7ak\u0131r A, Kaya C, Demirkan K, et al. Evaluation of Drug-Related problems of intensive care unit patients by clinical pharmacists: A retrospective study. Turk J Pharm Sci. 2024;21(4):274\u201383.","journal-title":"Turk J Pharm Sci"},{"issue":"Suppl 1","key":"13570_CR53","first-page":"A1067","volume":"3","author":"P Cuesta-Montero","year":"2015","unstructured":"Cuesta-Montero P, Rodr\u00edguez-Mat\u00edas M, Salinas-Pe\u00f1a C, et al. Incidence of medication errors in a surgical intensive care unit: analysis and improvement measures implemented. Intensive Care Med Exp. 2015;3(Suppl 1):A1067.","journal-title":"Intensive Care Med Exp"},{"issue":"5","key":"13570_CR54","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/cc9278","volume":"14","author":"JE Klopotowska","year":"2010","unstructured":"Klopotowska JE, Kuiper R, Van Kan HJ, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174.","journal-title":"Crit Care"},{"issue":"9","key":"13570_CR55","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1097\/CCM.0000000000002533","volume":"45","author":"SL Kane-Gill","year":"2017","unstructured":"Kane-Gill SL, Dasta JF, Buckley MS, Devlin JW, Erstad BL, Gray AW, et al. Clinical practice guideline: safe medication use in the ICU. Crit Care Med. 2017;45(9):e877\u201391.","journal-title":"Crit Care Med"},{"issue":"7","key":"13570_CR56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/jcpt.13628","volume":"47","author":"A Shahrami","year":"2022","unstructured":"Shahrami A, Amiri M, Ramezani S, Shakiba M. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. J Clin Pharm Ther. 2022;47(7):964\u201372.","journal-title":"J Clin Pharm Ther"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13570-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13570-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13570-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:12:21Z","timestamp":1761127941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13570-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13570"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13570-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Marmara University Faculty of Medicine Clinical Research Ethics Committee and was conducted according to the Declaration of Helsinki and Good Clinical Practise (GCP), under protocol code 09.2023.972, dated September 8, 2023, and with permission from the Provincial Health Directorate. Written informed consent was obtained from the adult (>\u200918 years old) patients who participated in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1375"}}